Infectious Diseases

>

Latest News

5 pediatric FDA decisions to watch for in Q2 2025Latest revision | Image Credit: © Araki Illustrations - © Araki Illustrations - stock.adobe.com.
5 pediatric FDA decisions to watch for in Q2 2025

March 28th 2025

A look ahead to 5 key regulatory decisions scheduled to take place during the second quarter of 2025, from a monoclonal antibody to topical psoriasis treatments.

VIMKUNYA chikungunya vaccine launches for ages 12 years and olderLatest revision | Image Credit: © ImageKing - © ImageKing - stock.adobe.com.
Vimkunya chikungunya vaccine launches for ages 12 years and older

March 18th 2025

Weekly review: Roflumilast 0.05% sNDA accepted, palforzia launches for US toddlers
Weekly review: Roflumilast 0.05% sNDA accepted, palforzia launches for US toddlers

March 3rd 2025

Image Credit: © ondrooo - stock.adobe.com.
CMV linked to increased necrotizing enterocolitis severity in premature infants

March 3rd 2025

Tina Tan, MD
Tina Tan, MD, comments on the measles outbreak in Texas, vaccine-preventable diseases

February 27th 2025

Latest CME Events & Activities

A Tethered Approach to Type 2 Diabetes Care – Connecting Insulin Regimens with Digital Technology

View More

Surv.AI Says™: What Clinicians and Patients Are Saying About Glucose Management in the Technology Age

View More

Addressing Healthcare Inequities: Tailoring Cancer Screening Plans to Address Inequities in Care

View More

Cases and Conversations™: Applying Best Practices to Prevent Shingles in Your Practice

View More

<1
...
3031323334
© 2025 MJH Life Sciences

All rights reserved.